Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
Endeavor Biomedicines, Inc.
Exelixis
Merck Sharp & Dohme LLC
Roswell Park Cancer Institute
University of California, San Francisco
Uppsala University
University of Washington
Minia University
RayzeBio, Inc.
University of Washington
Fudan University
University of Chicago
Rezolute
SWOG Cancer Research Network
Rezolute
National Cancer Institute (NCI)
National Cancer Center, Korea
RayzeBio, Inc.
Institut Paoli-Calmettes
IRCCS San Raffaele
Alliance for Clinical Trials in Oncology
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
UMC Utrecht
European Institute of Oncology
Fudan University
University of Chicago
Qilu Hospital of Shandong University
Universidad Nacional Autonoma de Mexico
Aadi Bioscience, Inc.
AC Camargo Cancer Center
University Medical Center Groningen
University Medical Center Groningen
Huazhong University of Science and Technology
Dana-Farber Cancer Institute
Société Française d'Endoscopie Digestive
Fudan University
Changhai Hospital
Sumitomo Pharma America, Inc.
Pfizer
European Institute of Oncology
Eastern Cooperative Oncology Group
Peking Union Medical College Hospital
University of California, San Francisco
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Guangxi Medical University